News

A newly approved targeted therapy for small cell lung cancer is at the forefront of a new type of drug for solid tumors.

Hollings was part of an international clinical trial that led to the FDA approval of a new drug to treat certain types of gliomas.

Two Hollings researchers are working together to develop a new way to get depression treatment to people with likely incurable cancer.

A new study aims to get a better understanding of what dual use of vapes and cigarettes looks like in real world usage.

MUSC scientists identify how cocaine triggers a specific protein in the brain to hijack normal brain circuitry and promote further drug taking.

The CREW program encourages early-career women in science to become entrepreneurs.

Too many lung cancer patients don't get all the biomarker testing they should have before beginning treatment. Dr. Adam Fox wants to change that.

Polyploid giant cancer cells, which are monstrously oversized and contain multiple nuclei, could be culprits in disease recurrence after cancer therapy.

External evaluation of MUSC’s telestroke program confirms that stroke center certification and stroke coordinators improve stroke-care metrics.

A new study is the first in the U.S. to show that an available generic drug could help people stop using e-cigarettes.